RT
The NHS is set to provide children in England with life-changing treatment for peanut allergies in a European first after the UK’s medical service signed a deal for the “pioneering” oral medication after a successful study.
Palforzia was found to reduce the severity of symptoms, such as anaphylaxis, after those with allergic reactions consume peanuts. The study conducted at Evelina London Children’s Hospital was described as having transformative effects for the lives of the kids who participated.
Sophie Pratt, mother of nine-year-old Emily who took part in the study, praised the treatment for allowing her daughter to be “free from limits and the fear that the tiniest mistake could put her life at risk.”
The two studies found that six in 10 participants, aged between four and 17, who experienced an allergic reaction to just 10mg of peanut protein at the start…
